MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease

    A.M. Rizos, P. Martinez-Martin, P. Reddy, M. Silverdale, K. Ashkan, A. Antonini, D. Calandrella, P. Odin, T. Henriksen, N. Bryndum, A. Glad, M.G. Kramberger, Z. Pirtošek, M. Trošt, T. van Laar, R. Katzenschlager, H.S. Dafsari, L. Timmermann, A. Storch, H. Reichmann, K. Ray Chaudhuri, On behalf of EUROPAR, The IPMDS Non-Motor PD Study Group (London, United Kingdom)

    Objective: To address comparative demographic and other variables for Parkinson's disease patients at baseline for infusion therapies (subcutaneous apomorphine (Apo), intrajejunal levodopa (IJLI)) and deep…
  • 2016 International Congress

    Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients: Final long-term non-motor, quality of life and safety results from the GLORIA registry

    K.R. Chaudhuri, Z. Pirtosek, B. Pickut, W. Poewe, F. Valldeoriola, L. Defebvre, R. Jech, P. Odin, C. Winkler, J. Szasz, K. Onuk, A. Yegin, L. Bergmann, A. Antonini (London, United Kingdom)

    Objective: To evaluate the tolerability and effect of levodopa-carbidopa intestinal gel (LCIG, designated in the US as carbidopa-levodopa enteral suspension) on non-motor symptoms (NMS), quality…
  • 2016 International Congress

    PARK-OMM – An osteopathic manipulative medicine protocol to improve motor function and balance in Parkinson’s disease

    S. Yao, K. de Vries, J. DiFrancisco-Donoghue, J. Mancini, M.K. Jung, G. Cheriyan, S. Curtis, A. Leder (Old Westbury, NY, USA)

    Objective: To evaluate the effects of a pre-defined Osteopathic Manipulative Medicine (OMM) treatment protocol (PARK-OMM) for 6 weeks compared to a 6-week controlled counseling period…
  • 2016 International Congress

    Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion

    T.R. Yamasaki, V.D. Smith, Y. Ai, D.M. Gash, P.T. Nelson, G.A. Gerhardt, J.T. Slevin (Lexington, KY, USA)

    Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…
  • 2016 International Congress

    Clinical effect and dose conversion of rytary (numient) in 50 consecutive patients with PD motor fluctuations

    N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

    Objective: To review the clinical use of a newer extended-release levodopa preparation in 50 consecutive patients with PD experiencing motor fluctuations on immediate-release levodopa. Background:…
  • 2016 International Congress

    Effects of the biodex stability system training on balance, gait and fatigue in Parkinson’s disease

    G. Singh, R. Pahwa, K.E. Lyons, Y. Colgrove, N.K. Sharma (Troy, NY, USA)

    Objective: The purpose of this study was to evaluate the effects of 4 weeks of BSS training on balance, gait and fatigue in PD patients.…
  • 2016 International Congress

    Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders

    B. Garcin, C. Hubsch, L. Lliescu, L. Naccache, M. Vidailhet, E. Fournier, F. Mesrati, E. Roze, B. Degos (Paris, France)

    Objective: To determine whether the beneficial effect of repeated transcranial magnetic stimulation (rTMS) in psychogenic movement disorders (PMDs) is the consequence of a cortical functioning…
  • 2016 International Congress

    Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

    M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)

    Objective: We performed an open study of delta-9-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray (Nabiximols, Sativex®) in 6 patients with suboptimal responsive adult-onset dystonia. Background: Cannabinoids…
  • 2016 International Congress

    Can intraoperative clinical testing really predict the effects of deep brain stimulation in the subthalamic nucleus?

    J. Blume, J. Schlaier, F. Zeman, E. Rothenfußer, A. Brawanski, U. Bogdahn, M. Lange (Regensburg, Germany)

    Objective: To evaluate whether stimulation-induced therapeutic and side effects of the permanent electrode are predictable by intraoperative test stimulation with clinical examination. Background: Intraoperative test…
  • 2016 International Congress

    Multiple-source current steering in bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease: Our experience

    J.M. Cardenas Prieto, P.A. Millan Giraldo (Cali, Colombia)

    Objective: To evaluate the efficacy and side effects of a multiple-source, constant-current device in a Latin-American population of patients with PD. Background: Timmermann et al.…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley